Advances in novel molecular typing and precise treatment strategies for small cell lung cancer

查看全文 作　　者：Rilan [1]Bai;Lingyu [1]Li;Xiao [1]Chen;Yuguang [1]Zhao;Wei [1]Song;Huimin [1]Tian;Jiuwei [1]Cui

机构地区：[1]Cancer Center,the First Hospital of Jilin University,Changchun 130021,China

出　　处：《Chinese Journal of Cancer Research》索引2021年第33卷第4期,共13页

基　　金：supported by grants from Jilin Provincial Key Laboratory of Biological Therapy(No.20170622011JC);Jilin Provincial Science and Technology Department(No.20190303146SF);Jilin Province Finance Department(No.2018SCZWSZX-010)。 摘　　要：Small cell lung cancer(SCLC)is a high-grade neuroendocrine(NE)cancer characterized by high circulating tumor-cell burden and early extensive metastasis.Considering the complexity of SCLC genes and the immune microenvironment,their unique molecular heterogeneity profiles have been continuously explored.The understanding of SCLC subtypes has recently changed from traditional'classical'and'variant'types to'NE'and'non-NE'phenotypes and to the subtypes defined by major transcriptional regulators,which indicates the gradual revelation of high intratumoral heterogeneity and plasticity characteristics of SCLCs.Advances in genomics as well as the development of single-cell sequencing analysis and new preclinical models have helped investigators gain many new insights into SCLCs and the development of targeted therapy and immunotherapy strategies.This article provides an overview of changes in molecular typing,tumor heterogeneity,and plasticity and that of advances in the precise treatment of different subtypes of SCLC. 关键词：Small cell lung cancer transcription factors tumor heterogeneity PLASTICITY IMMUNE

相关文献

参考文献（72）
引证文献（1）
耦合文献（17）

参考文献(72)

引证文献(1)

耦合文献(17)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Advances in novel molecular typing and precise treatment strategies for small cell lung cancer

参考文献(72)

引证文献(1)

耦合文献(17)

用户提示